Specialized Disclosure Report (sd)
May 29 2020 - 2:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form SD
Specialized Disclosure Report
BRUKER CORPORATION
(Exact name of registrant as specified in
its charter)
DELAWARE
|
|
000-30833
|
|
04-3110160
|
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification
Number)
|
40 Manning Road, Billerica, MA 01821
(Address of principal executive offices)
(Zip Code)
Gerald N. Herman
|
|
(978) 663-3660
|
(Name and telephone number, including area code, of the person to contact in
connection with this report.)
|
Check the appropriate
box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form
applies:
xRule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2019.
|
Section 1 – Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
Pursuant to Rule 13p-1 (“Rule 13p-1”) promulgated
under the Securities Exchange Act of 1934, as amended, Bruker Corporation (the “Company”) has filed this Specialized
Disclosure Report (“Form SD”) for the reporting period January 1, 2019 to December 31, 2019.
A description of the measures the Company undertook to exercise
due diligence on the source and chain of custody of conflict minerals contained in its Products is provided in the Conflict Minerals
Report attached hereto as Exhibit 1.01. A copy of the Company’s Conflict Minerals Policy is publicly available at www.bruker.com.
Item 1.02 Exhibits
As specified in Section 2, Item 2.01 of this Form SD, the Company
is hereby filing its Conflict Minerals Report as Exhibit 1.01 to this Form SD.
Section 2 – Exhibits
Item 2.01 Exhibits
The following exhibit is filed as part of this report:
Exhibit 1.01 — Conflict Minerals Report of Bruker Corporation
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized
undersigned.
Bruker Corporation
By:
|
/s/
GERALD N. HERMAN
|
Date: May 29, 2020
|
|
Gerald N. Herman
|
|
|
Chief
Financial Officer and Vice President
|
|
|
(Principal
Financial Officer and Principal Accounting Officer)
|
|
Exhibit Index
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Apr 2023 to Apr 2024